CRISPR Science Prevails; Critics Proven ‘Off-Target’ – American Council on Science and Health
American Council on Science and Health |
CRISPR Science Prevails; Critics Proven ‘Off-Target’
American Council on Science and Health New scientific discoveries should be held to a high standard. When they happen to be incredibly powerful and have the ability to edit the human genome, they should be held to the highest standard. It was not surprising then, that a paper published last … |
Science Magazine |
Two controversial stem cell trials could harm patients, critics say
Science Magazine LIVERPOOL, U.K.—Replacing a failing windpipe, or trachea, with one partially made from a patient’s own stem cells once looked like the cutting edge of regenerative medicine. But the concept took a severe blow in 2016 with the dramatic fall of Paolo … |
Philadelphia Business Journal |
Exclusive: Penn patient shares the story of her CAR–T cell therapy journey
Philadelphia Business Journal Nicole Gularte — who was once given three-to-five weeks to live — isn’t just a cancer survivor, she’s a seven-time leukemia survivor. She credits the CAR–T cell therapy developed by researchers at the University of Pennsylvania’s Abramson Cancer … |
ALS News Today |
BrainStorm Adds Canadians to US Trial of Its ALS Stem Cell Therapy
ALS News Today It decided to add the Canadians when a number of them expressed interest in participating, BrainStorm said. The trial (NCT03280056) is investigating the safety and effectiveness of repeated doses of NurOwn. The Canadians’ trial site will be at the … |